article thumbnail

Pulmonary transplant complications: a radiologic review

Journal of Cardiothoracic Surgery

Lung transplantation has become the definitive treatment for end stage respiratory disease. Numbers and survival rates have increased over the past decade, with transplant recipients living longer and with gre.

article thumbnail

Double lung transplantation is better than single lung transplantation for end-stage chronic obstructive pulmonary disease: a meta-analysis

Journal of Cardiothoracic Surgery

Lung transplantation is one of the most common treatment options for patients with end-stage chronic obstructive pulmonary disease. However, the choice between single and double lung transplantation for these.

article thumbnail

Pulmonary artery mass with PIK3CA mutation after orthotopic heart transplantation

Journal of Cardiothoracic Surgery

Patients can develop de novo malignancies following orthotopic heart transplantation. However, vascular tumors are not commonly described in this population.

article thumbnail

Latest Medical News: Partial Heart Transplant of an Infant

Wellnest

Introduction: Wellnest brings you , the latest medical news where an infant successfully received a partial heart transplant! In a remarkable leap forward for pediatric cardiac care, a groundbreaking partial heart transplant procedure has emerged as a beacon of hope for infants facing severe congenital heart conditions.

article thumbnail

PO-05-146 MECHANISMS OF ATYPICAL REENTRY FLUTTER FOLLOWING LUNG TRANSPLANTATION: A NOVEL NOMENCLATURE

HeartRhythm

Atrial tachycardia (AT) involving the surgical cuff between the donor pulmonary veins (dPV) and recipient left atrium (rLA) following lung transplantation (LT) typically occurs in the late postoperative period.

article thumbnail

Healthy omega-3 fats may slow deadly pulmonary fibrosis

Science Daily - Heart Disease

Higher levels of omega-3, the healthy fat found in fish and nuts, were associated with better lung function and longer transplant-free survival.

Pulmonary 105
article thumbnail

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Open Heart

Background The treatment of pulmonary hypertension (PH) has improved rapidly in recent decades. Treatment escalation was defined as an additional pulmonary arterial hypertension (PAH) drug, pulmonary endarterectomy, percutaneous balloon angioplasty or bilateral lung transplantation.